A Pharmacologic Update: New Treatments for Patients with Cardiovascular Disease.

Abstract

Pharmacologic agents are a key part of the medical armamentarium aimed at reducing the significant morbidity and mortality caused by cardiovascular disease (CVD). In recent years, the landscape of CVD treatment has evolved with the development of new medication classes and the repurposing of existing medications for new indications. This article provides nurses with a pharmacologic update on new and emerging therapies for the treatment of hypertrophic cardiomyopathy, familial hypercholesterolemia, and heart failure. The authors review clinical indications, pharmacology, practical considerations for the safe and appropriate use of these medications, and implications for nurses.

• Authors: Elizabeth Radchik, Leslie L Davis, Ciantel A Blyler
• Journal: The Nursing clinics of North America (Nurs Clin North Am) Vol. 58 Issue 3 Pg. 389-403 (09 2023) ISSN: 1558-1357 [Electronic] United States
• PMID: 37536788 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2023 Elsevier Inc. All rights reserved.

Topics

• Humans
• Cardiovascular Diseases (drug therapy)
• Hyperlipoproteinemia Type II